Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-012826

Chief Financial Officer sold 7,489 shares at $5.29 ($39,647)

From the SEC's structured data for this filing

Trades in this filing

Ondrey Aaron · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-04-04 Sale : show line 1 in the form −7,489 $5.29 $39,647 129,650 D
Open-market sales · 7,489 sh · avg $5.29 · $39,647
Loading xslF345X05/form4.xml…